| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1529 | 2019 |
| T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017 | 727 | 2017 |
| Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations RN Alcalay, OA Levy, CH Waters, S Fahn, B Ford, SH Kuo, P Mazzoni, ... Brain 138 (9), 2648-2658, 2015 | 394 | 2015 |
| The neuropathology of genetic Parkinson's disease M Poulopoulos, OA Levy, RN Alcalay Movement Disorders 27 (7), 831-842, 2012 | 332 | 2012 |
| Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease LV Kalia, AE Lang, LN Hazrati, S Fujioka, ZK Wszolek, DW Dickson, ... JAMA neurology 72 (1), 100-105, 2015 | 323 | 2015 |
| Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study RN Alcalay, E Caccappolo, H Mejia-Santana, MX Tang, L Rosado, ... Neurology 78 (18), 1434-1440, 2012 | 294 | 2012 |
| Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature SA Schneider, RN Alcalay Movement Disorders 32 (11), 1504-1523, 2017 | 280 | 2017 |
| Impact of the COVID‐19 pandemic on Parkinson's disease and movement disorders SM Papa, P Brundin, VSC Fung, UJ Kang, DJ Burn, C Colosimo, ... Movement disorders clinical practice 7 (4), 357, 2020 | 261 | 2020 |
| The association between Mediterranean diet adherence and Parkinson's disease RN Alcalay, Y Gu, H Mejia‐Santana, L Cote, KS Marder, N Scarmeas Movement Disorders 27 (6), 771-774, 2012 | 249 | 2012 |
| Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes RN Alcalay, T Dinur, T Quinn, K Sakanaka, O Levy, C Waters, S Fahn, ... JAMA neurology 71 (6), 752-757, 2014 | 213 | 2014 |
| Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study RN Alcalay, E Caccappolo, H Mejia-Santana, MX Tang, L Rosado, ... Archives of neurology 67 (9), 1116-1122, 2010 | 183 | 2010 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 178 | 2020 |
| Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study A Siderowf, L Concha-Marambio, DE Lafontant, CM Farris, Y Ma, ... The Lancet Neurology 22 (5), 407-417, 2023 | 167 | 2023 |
| Arm swing as a potential new prodromal marker of Parkinson's disease A Mirelman, H Bernad‐Elazari, A Thaler, E Giladi‐Yacobi, T Gurevich, ... Movement Disorders 31 (10), 1527-1534, 2016 | 166 | 2016 |
| Ser (P)‐1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease KB Fraser, AB Rawlins, RG Clark, RN Alcalay, DG Standaert, N Liu, ... Movement Disorders 31 (10), 1543-1550, 2016 | 163 | 2016 |
| Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium K Marder, Y Wang, RN Alcalay, H Mejia-Santana, MX Tang, A Lee, ... Neurology 85 (1), 89-95, 2015 | 159 | 2015 |
| Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry AJ Lee, Y Wang, RN Alcalay, H Mejia‐Santana, R Saunders‐Pullman, ... Movement Disorders 32 (10), 1432-1438, 2017 | 155 | 2017 |
| Genetic forms of Parkinson's disease CY Kim, RN Alcalay Seminars in neurology 37 (02), 135-146, 2017 | 150 | 2017 |
| Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ... The Lancet Neurology 16 (8), 620-629, 2017 | 147 | 2017 |
| GBA mutations are associated with rapid eye movement sleep behavior disorder Z Gan‐Or, A Mirelman, RB Postuma, I Arnulf, A Bar‐Shira, Y Dauvilliers, ... Annals of clinical and translational neurology 2 (9), 941-945, 2015 | 142 | 2015 |
